Mednix Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 10-12-2024
- Paid Up Capital ₹ 0.50 M
as on 10-12-2024
- Company Age 17 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 4.00 M
as on 10-12-2024
- Revenue -71.18%
(FY 2020)
- Profit 65.15%
(FY 2020)
- Ebitda 69.05%
(FY 2020)
- Net Worth -28.61%
(FY 2020)
- Total Assets -41.09%
(FY 2020)
About Mednix Lifesciences
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company has closed loans amounting to ₹4.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sumit Gupta and Amit Gupta serve as directors at the Company.
- CIN/LLPIN
U24233DL2007PTC167912
- Company No.
167912
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Sep 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Mednix Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sumit Gupta  | Director | 20-Mar-2023 | Current |
| Amit Gupta | Additional Director | 16-Apr-2013 | Current |
Financial Performance of Mednix Lifesciences.
Mednix Lifesciences Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 71.18% decrease. The company also saw a substantial improvement in profitability, with a 65.15% increase in profit. The company's net worth observed a substantial decline by a decrease of 28.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mednix Lifesciences?
In 2017, Mednix Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Corporation Bank Creation Date: 20 Mar 2010 | ₹3.00 M | Satisfied |
Corporation Bank Creation Date: 20 Feb 2009 | ₹1.00 M | Satisfied |
How Many Employees Work at Mednix Lifesciences?
Unlock and access historical data on people associated with Mednix Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mednix Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mednix Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
